Analyst Research Report Snapshot

Title:

CONSORT MEDICAL - MOMENTUM BUILDING

Price:

$10.00

Provider:

Edison Investment Research

Date:

20 Jun 2011

Pages:

12

Type:

AcrobatPDF

Companies referenced:

CSRT.L AMSU.L BIOC.CA GLAX.KA GLAX.NS GLSK.DH GLSM.NS GSK.L GXIG.DE IDH.L OPTS.L REDY.NS SN.L YPSN.S

Available for Immediate Download
Summary:

Consort Medical returned to growth in FY11; with revenue and profit expansion in both its Bespak and King Systems divisions. Cost savings from restructuring are largely secured, so the focus is on top-line growth through pipeline expansion/progress and business development. Management’s medium-term target of double-digit profit growth should be supported by new product launches, further autoinjector device contracts (one is imminent), improved margins and potential M&A. Consort remains a defensive, and dividend paying, growth opportunity for investors.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.